Xenobiotic-metabolizing cytochromes P450 in ontogeny: Evolving perspective

Drug Metabolism Reviews

Volumn 36, Issue 3-4, 2004, Pages 549-568

  Choudhary, Dharamainder ^a   Jansson, Ingela ^a   Sarfarazi, Mansoor ^a   Schenkman, John B ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

CYP; Cytochrome P450; Developmental P450s; Eicosanoids; Retinoic acid

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1B1; CYTOCHROME P450 ISOENZYME; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4 RECEPTOR; ICOSANOID; MINERALOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; STEROID; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

CELL CYCLE; CHOLESTEROL SYNTHESIS; EMBRYO; ENZYME ACTIVITY; ENZYME INDUCTION; FETUS; HUMAN; ICOSANOID METABOLISM; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; ORTHOLOGY; PHYLOGENY; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SPECIES DIFFERENCE; STEROID METABOLISM; STEROIDOGENESIS; TRANSCRIPTION REGULATION; VITAMIN METABOLISM; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; XENOBIOTICS;

EID: 7544225528     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-200033447     Document Type: Review

References (114)

1. Abu-Abed, S., Dolle, P., Metzger, P., Beckett, B., Chambon, P., Petkovich, M. (2001). The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev. 15:226-240.
2. Bean, R., Seckl, J. R., Lathe, R., Martin, C. (2001). Ontogeny of the neurosteroid enzyme CYP7b in the mouse. Mol Cell. Endocrinol. 174:137-144.
3. Capdevilla, J. H., Falck, J. R., Harris, R. C. (2000). Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenases. J. Lipid Res. 41:163-181.
4. Carpenter, S. P., Lasker, J. M., Raucy, J. L. (1996). Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol. Pharmacol. 49:260-268.
5. Chavez, V. M., Marques, G., Delbecque, J. P., Kobayashi, K., Hollingsworth, M., Burr, J., Natzle, J., O'Connor, M. B. (2000). The drosophila disembodied gene controls late embryonic morphogenesis and codes for a cytochrome P450 enzyme that regulates embryonic ecdysone levels. Development 127:4115-4126.
6. Chen, H., Howald, W. N., Juchau, M. R. (2000). Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P450 cytochromes. Drug Metab. Dispos. 28:315-322.
7. Chen, S., Glawischnig, E., Jorgensen, K., Naur, P., Jorgensen, B., Olsen, C. E., Hansen, C. H., Rasmussen, H., Pickett, J. A., Halkier, B. A. (2003). CYP79F1 and CYP79F2 have distinct functions in the biosynthesis of aliphatic glucosinolates in Arabidopsis. Plant J. 33:923-937.
8. Chen, Y., Liu, Y. Q., Su, T., Ren, X., Shi, L., Liu, D., Gu, J., Zhang, Q. Y., Ding, X. (2003). Immunoblot analysis and immunohistochemical characterization of CYP2A expression in human olfactory mucosa. Biochem. Pharmacol. 66:1245-1251.
9. Cheng, K.-C., Schenkman, J. B. (1983). Testosterone metabolism by cytochrome P-450 isozymes RLM3 and RLM5 and by microsomes. Metabolite identification. J. Biol. Chem. 258:11738-11744.
10. Cheng, K.-C., Schenkman, J. B. (1984). Metabolism of progesterone and estradiol by microsomes and purified cytochrome P450 RLM3 and RLM5. Drug Metab. Dispos. 12:222-234.
11. Cheng, J. B., Motola, D. L., Mangelsdorf, D. J., Russell, D. W. (2003). De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 278:38084-38093.
12. Choudhary, D., Jansson, I., Stoilov, I., Sarfarazi, M., Schenkman, J. B. (2004). Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1B1. Drug Metab. Dispos. 32:840-847.
13. Choudhary, D., Jansson, I., Schenkman, J. B., Sarfarazi, M., Stoilov, I. (2003). Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch. Biochem. Biophys. 414:91-100.
14. Chuang, S. S., Helvig, C., Taimi, M., Ramshaw, H. A., Collop, A. H., Amad, M., White, J. A., Petkovich, M., Jones, G., Korczak, B. (2004). CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes {omega}- and ({omega}-1)-hydroxylation of fatty acids. J. Biol. Chem. 279:6305-6314.
15. Clagett-Dame, M., DeLuca, H. F. (2002). The role of vitamin A in mammalian reproduction and embryonic development. Annu. Rev. Nutr. 22:347-381.
16. Clarke, R., Liu, M. C., Bouker, K. B., Gu, Z., Lee, R. Y., Zhu, Y., Skaar, T. C., Gomez, B., O'Brien, K. O., Wang, Y., Hilskivi-Clarke, L. A. (2003). Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22:7316-7339.
17. Cowart, L. A., Wei, S., Hsu, M.-H., Johnson, E. F., Krishna, M. U., Falck, J. R., Capdevilla, J. H. (2002). The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator- activated receptor ligands. J. Biol. Chem. 277:35105-35112.
18. Cude, K. J., Dixon, S. C., Guo, Y. D., Lisella, J., Figg, W. D. (1999). The androgen receptor: genetic considerations in the development and treatment of prostate cancer. Journal of Molecular Medicine 77:419-426.
19. Daikh, B. E., Lasker, J. M., Raucy, J. L., Koop, D. R. (1994). Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes p450 2C8 and 2C9. J. Pharmacol. Exp. Ther. 271:1427-1433.
20. Duester, G. (2000). Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 267:4315-4324.
21. Favreau, L. V., Schenkman, J. B. (1987). Decrease in the levels of a constitutive cytochrome P-450 (RLM5) in hepatic microsomes of diabetic rats. Biochem. Biophys. Res. Commun. 142:623-630.
22. Favreau, L. V., Schenkman, J. B. (1988). Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozocin-induced diabetes and during insulin treatment. Diabetes 37:577-584.
23. Favreau, L. V., Malchoff, D. M., Mole, J. E., Schenkman, J. B. (1987). Responses to insulin by two forms of rat hepatic microsomal cytochrome P-450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetes. J. Biol. Chem. 262:14319-14326.
24. Fleming, I. (2001). Cytochrome P450 enzymes in vascular homeostasis. Circ. Res. 89:753-762.
25. Fujii, H., Sato, T., Kaneko, S., Gotoh, O., Fujii-Kuriyama, Y., Osawa, K., Kato, S., Hamada, H. (1997). Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J. 16:4163-4173.
26. Gotoh, O. (1992). Substrate recognition sites in cytochrome-P450 family-2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 267:83-90.
27. Greim, H., Schenkman, J. B., Klotzbucher, M., Remmer, H. (1970). The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. Biochim. Biophys. Acta 201:20-25.
28. Gu, J., Su, T., Chen, Y., Zhang, Q.-Y., Ding, X. (2000). Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity. Toxicol. Appl. Pharmacol. 165:158-162.
29. Hakkola, J., Raunio, H., Purkunen, R., Saarikoski, S., Vahakangas, K., Pelkonen, O., Edwards, R. J., Boobis, A. R., Pasanen, M. (2001). Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol. Neonate 80:193-201.
30. Haselbeck, R. J., Hoffmann, I., Duester, G. (1999). Distinct functions for Aldh1 and Raldh2 in the control of ligand production for retinoid signaling pathways. Dev. Genet. 25:353-364.
31. Itoh, S., Satoh, M., Abe, Y., Hashimoto, H., Yanagimoto, T., Kamataki, T. (1994). A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver. Eur. J. Biochem. 226:877-882.
32. Jansson, I., Mole, J., Schenkman, J. B. (1985). Purification and characterization of a new form (RLM2) of liver microsomal cytochrome P-450 from untreated rat. J. Biol. Chem. 260:7084-7093.
33. Jansson, I., Stoilov, I., Sarfarazi, M., Schenkman, J. B. (2001). Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism. Pharmacogenetics 11:793-801.
34. Jia, K., Albert, P. S., Riddle, D. L. (2002). Daf-9, a cytochrome P450 regulating C. elegans larval development and adult longevity. Development 129:221-231.
35. Johnsrud, E. K., Koukouritaki, S. B., Divakaran, K., Brunengraber, L. L., Hines, R. N., McCarver, D. G. (2003). Human hepatic CYP2E1 expression during development. J. Pharmacol. Exp. Ther. 307:402-407.
36. Juchau, M. R. (1997). Chemical teratogenesis in humans: biochemical and molecular mechanisms. Prog. Drug Res. 49:25-92.
37. Juchau, M. R., Boutelot-Bochan, H., Huang, Y. (1998). Cytochrome P450-dependent biotransformation of xenobiotics in human and rodent embryonic tissues. Drug Metab. Rev. 30:541-568.
38. Kalyankrishna, S., Malik, K. U. (2003). Norepinephrine-induced stimulation of p38 mitogen-activated protein kinase is mediated by arachidonic acid metabolites generated by activation of cytosolic phospholipase A2 in vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 304:761-772.
39. Keeney, D. S., Waterman, M. R. (1999). Two novel sites of expression of NADPH cytochrome P-450 reductase during murine embryogenesis: limb mesenchyme and developing olfactory neuroepithelia. Dev. Dyn. 216:511-517.
40. Keeney, D. S., Ikeda, Y., Waterman, M. R., Parker, K. L. (1995a). Cholesterol side-chain cleavage cytochrome P450 gene expression in the primitive gut of the mouse embryo does not require steroidogenic factor 1. Mol. Endocrinol. 9:1091-1098.
41. Keeney, D. S., Jenkins, C. M., Waterman, M. R. (1995b). Developmentally regulated expression of adrenal 17 alpha-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136:4872-4879.
42. Keeney, D. S., Skinner, C., Traverse, J. B., Capdevila, J. H., Nanney, L. B., King, L. E. Jr., Waterman, M. R. (1998). Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem. 273:32071-32079.
43. Keller, J. M., Collet, P., Bianchi, A., Huin, C., Bouillaud-Kremarik, P., Becuwe, P., Schohn, H., Domenjoud, L., Dauca, M. (2000). Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease. Int. J. Dev. Biol. 44:429-442.
44. Keshamouni, V. G., Reddy, R. C., Aremberg, D. A., Joel, B., Thannickal, V. J. (2004). Peroxysome proliferator-activated receptor-g activation inhibits tumor progression in non-small-cell lung cancer. Oncogene 23:100-108.
45. Kessel, M. (1992). Respecification of vertebral identities by retinoic acid. Development 115:487-501.
46. Kim, G.-T., Tsukaya, H., Uchimiya, H. (1998). The ROTUNDIFOLIA3 gene of Arabidopsis thaliana encodes a new member of the cytochrome P-450 family that is required for the regulated polar elongation of leaf cells. Genes Dev. 12:2381-2391.
47. Kupfer, D. (1993). Endogenous substrates of monooxygenases: fatty acids and prostaglandines. In: Schenkman, J. B., Greim, H., eds. Hepatic Cytochrome P-450 Monooxygenase System. Berlin: Springer-Verlag, pp. 157-187.
48. Lewis, D. F. V., Gillam, E. M. J., Everett, S. A., Shimada, T. (2003). Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism. Chem. Biol. Interact. 145:281-295.
49. Libby, R. T., Smith, R. S., Savinova, O. V., Zabaleta, A., Martin, J. E., Gonzalez, F. J., John, S. W. (2003). Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299:1578-1581.
50. Luo, G., Zeldin, D. C., Blaisdell, J. A., Hodgson, E., Goldstein, J. A. (1998). Cloning and expression of murine Cyp2cs and their ability to metabolize arachidonic acid. Arch. Biochem. Biophys. 357:45-57.
51. Ma, J., Qu, W., Scarborough, P. E., Tomer, K. B., Moomaw, C. R., Maronpot, R., Davis, L. S., Breyer, M. D., Zeldin, D. C. (1999). Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J. Biol. Chem. 274:17777-17788.
52. Maden, M. (1999). Heads or tails? Retinoic acid will decide. BioEssays 21:809-812.
53. Maden, M., Sonneveld, E., van der Saag, R. T., Gale, E. (1998). The distribution of endogenous retinoic acid in the chick embryo: implications for developmental mechanisms. Development 125:4133-4144.
54. Maier, K. G., Roman, R. J. (2001). Cytochrome P450 metabolites of arachionic acid in the control of renal function. Curr. Opin. Nephrol. Hypertens. 10:81-87.
55. Maraguchi, H., Kamada, T. (2000). A mutation in the eln2 gene encoding a cytochrome 450 of Coprinus cinereus affects mushroom morphogenesis. Fungal Genet. Biol. 29:49-59.
56. Marill, J., Cresteil, T., Lanotte, M., Chabot, G. G. (2000). Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol. Pharmacol. 58:1341-1348.
57. McCaffery, P., Wagner, E., O'Neil, J., Petkovich, M., Drager, U. C. (1999). Dorsal and ventral retinal territories defined by retinoic acid synthesis, break-down and nuclear receptor expression. Mech. Dev. 82:119-130.
58. Morgan, E., MacGeoch, C., Gustafsson, J.-A. (1985). Sexual differentiation of cytochrome P-450 in rat liver. Mol. Pharmacol. 27:471-479.
59. Murakami, K., Ide, T., Suzuki, M., Mochizuki, T., Kadowaki, T. (1999). Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem. Biophys. Res. Commun. 260:609-613.
60. Na, H. K., Surh, Y. J. (2003). Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Biochem. Pharmacol. 66:1381-1391.
61. Nebert, D. W. (1991). Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 5:1203-1214.
62. Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Loper, J. C., Sato, R., Waterman, M. R., Waxman, D. J. (1991). The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 10:1-14.
63. Nelson, D. R. (2003). Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution Arch. Biochem. Biophys. 409:18-24.
64. Niederreither, K., Subbarayan, V., Dollé, P., Chambon, P. (1999). Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat. Genet. 21:444-448.
65. Node, K., Ruan, X. L., Dai, J., Yang, S. X., Graham, L., Zeldin, D. C., Liao, J. K. (2001). Activation of Galphas mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J. Biol. Chem. 276:15983-15989.
66. O'Flaherty, J. T., Rogers, L. C., Chadwell, B. A., Owen, J. S., Rao, A., Cramer, S. D., Daniel, L. W. (2002). 5(S)-Hydroxy-6,8,11,14-E,Z,Z,Z- eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism. Cancer Res. 62:6817-6819.
67. Otto, D. M., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., Wolf, C. R. (2003). Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol. Cell. Biol. 23:6103-6116.
68. Pezzi, V., Mathis, J. M., Rainey, W. E., Can, B. R. (2003). Profiling transcript levels for steroidogenic enzymes in fetal tissues. J. Steroid Biochem. Mol. Biol. 87:181-189.
69. Pottenger, L. H., Christou, M., Jefcoate, C. R. (1991). Purification and immunological characterization of a novel cytochrome-P450 from C3H/10T1/2 cells. Arch. Biochem. Biophys. 286:488-497.
70. Reintanz, B., Lehnen, M., Reichelt, M., Gershenzon, J., Kowalczyk, M., Sandberg, G., Godde, M., Uhl, R., Palme, K. (2001). Bus, a Bushy arabidopsis cyp79f1 knockout mutant with abolished synthesis of short-chain aliphatic glucosinolates. Plant Cell 13:351-367.
71. Remmer, H., Schenkman, J., Estabrook, R. W., Sasame, H., Gillette, J., Narasimhulu, S., Cooper, D. Y., Rosenthal, O. (1966). Drug interaction with hepatic microsomal cytochrome. Mol. Pharmacol. 2:187-190.
72. Remmer, H., Greim, H., Schenkman, J. B., Estabrook, R. W. (1967). Methods for the elevation of hepatic microsomal mixed function oxidase levels and cytochrome P-450. Methods Enzymol. 10:703-708.
73. Remmer, H., Estabrook, R. W., Schenkman, J., Greim, H. (1968). Reaction of drugs with microsomal liver hydroxylase: its influence on drug action. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 259:98-116.
74. Rich, K. J., Boobis, A. R. (1997). Expression and inducibility of P450 enzymes during liver ontogeny. Microsc. Res. Tech. 39:424-435.
75. Rich, K. J., Foster, J. R., Edwards, R. J., Davies, D. S., Boobis, A. R. (1993). Ontogenetic development of the distribution of constitutive and 3-methylcholanthrene-induced CYP1A1 and CYP1A2 in rabbit liver. J. Histochem. Cytochem. 41:915-925.
76. Riddiford, L. M., Cherbas, P., Truman, J. W. (2000). Ecdysone receptors and their biological actions. Vitam. Horm. 60:1-73.
77. Rifkind, A. B., Lee, C., Chang, T. K., Waxman, D. J. (1995). Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320:380-389.
78. Roberts, E. S., Vaz, A. D. N., Coon, M. J. (1992). Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal. Mol. Pharmacol. 41:427-433.
79. Roberts, R. A., Chevalier, S., Hasmall, S. C., James, N. H., Cosulich, S. C., Macdonald, N. (2002). PPAR alpha and the regulation of cell division and apoptosis. Toxicology 181-182:167-170.
80. Sakai, Y., Meno, C., Fujii, H., Nishino, J., Shiratori, H., Saijoh, Y., Rossant, J., Hamada, H. (2001). The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. Genes Dev. 15:213-225.
81. Sarfarazi, M., Stoilov, I. (2000). Molecular genetics of primary congenital glaucoma. Eye 14:422-428.
82. Sarfarazi, M., Stoilov, I., Schenkman, J. B. (2003). Genetics and biochemistry of primary congenital glaucoma. Ophthal. Clin. N. Am. 16:543-554.
83. Savas, Ü., Carstens, C.-P., Jefcoate, C. R. (1997). Biological oxidations and P450 reactions. Recombinant mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Arch. Biochem. Biophys. 347:181-192.
84. Schenkman, J. B., Greim, H. (1993). Cytochrome P450. In: Born, G., Cuatrecasas, P., Herken, H., eds. Handbook of Experimental Pharmacology. Berlin: Springer-Verlag.
85. Schenkman, J. B., Frey, I., Remmer, H., Estabrook, R. W. (1967a). Sex differences in drug metabolism by rat liver microsomes. Mol. Pharmacol. 3:516-525.
86. Schenkman, J. B., Remmer, H., Estabrook, R. W. (1967b). Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol. Pharmacol. 3:113-123.
87. Schenkman, J. B., Choudhary, D., Jansson, I., Sarfarazi, M., Stoilov, I. (2003). Involvement of cytochromes P450 in development. Proc. Ind. Nat. Sci. Acad. B69:929-941.
88. Shankaranarayanan, P., Nigam, S. (2003). IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15- hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor gamma transcription factor. J. Immunol. 170:887-894.
89. Shen, A. L., O'Leary, K. A., Kasper, C. B. (2002). Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem. 277:6536-6541.
90. Shimada, T., Yamazaki, H., Mimura, M., Wakamiya, N., Ueng, Y.-F., Guengerich, F. P., Inui, Y. (1996). Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab. Dispos. 24:515-522.
91. Smith, G., Wolf, C. R., Deeni, Y. Y., Dawe, R. S., Evans, A. T., Comrie, M. M., Ferguson, J., Ibbotson, S. H. (2003). Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343.
92. Snyder, G. D., Krishna, U. M., Falck, J. R., Spector, A. A. (2002). Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 283:H1936-H1942.
93. Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J., Zaya, M. J. (2003). Developmental expression of the major human hepatic CYP3A enzymes. J. Pharmacol. Exp. Ther. 307:573-582.
94. Stoilov, I., Akarsu, A. N., Sarfarazi, M. (1997). Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome ep21. Hum. Mol. Genet. 6:641-647.
95. Stoilov, I., Akarsu, A. N., Alozie, I., Child, A., Barsoum-Homsy, M., Turacli, M. E., Or, M., Lewis, R. A., Ozdemir, N., Brice, G., Aktan, S. G., Chevrette, L., Coca-Prados, M., Sarfarazi, M. (1998). Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am. J. Hum. Genet. 62:573-584.
96. Stoilov, I., Jansson, I., Sarfarazi, M., Schenkman, J. B. (2001). Roles of cytochrome P450 in development. Drug Metab. Drug Interac. 18:1-23.
97. Tahayato, A., Dolle, P., Petkovich, M. (2003). Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. Gene Expr. Patterns 3:449-454.
98. Taimi, M., Helvig, C., Wisniewski, J., Ramshaw, H., White, J., Amad, M., Korczak, B., Petkovich, M. (2004). A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J. Biol. Chem. 279:77-85.
99. Thummel, K. E., Schenkman, J. B. (1990). Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Mol. Pharmacol. 37:119-129.
100. Thummel, K. E., Hopfer, S. M., Schenkman, J. B. (1991). Compositional changes in sexually differentiated forms of hepatic cytochrome P-450 in the diabetic rat. In: E., A., Schenkman, J. B., Hodgson, E., eds. Molecular Aspects of Monooxygenases and Bioactivation of Toxic Compounds. New York: Plenum Press, pp. 247-256.
101. Trofimova-Griffin, M. E., Juchau, M. R. (1998). Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues. Biochem. Biophys. Res. Commun. 252:487-491.
102. Trofimova-Griffin, M. E., Juchau, M. R. (2002). Developmental expression of cytochrome CYP26B1 (P450RAI-2) in human cephalic tissues. Brain Res. Dev. Brain Res. 136:175-178.
103. Tsukaya, H. (2002). The leaf index: heteroblasty, natural variation, and the genetic control of polar processes of leaf expansion. Plant Cell Physiol. 43:372-378.
104. Warren, J. T., Petryk, A., Marqués, G., Jarcho, M., Parvy, J.-P., Dauphin-Villemant, C., O'Conner, M. B., Gilbert, L. I. (2002). Molecular and biochemical characterization of two P450 enzymes in the ecdysteroidogenic pathway of Drosophila melanogaster. Proc. Natl. Acad. Sci. U. S. A. 99:11043-11048.
105. Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., Korzekwa, K. (1991). Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome-P450s. Arch. Biochem. Biophys. 290:160-166.
106. White, J. A., Beckett-Jones, B., Guo, Y. D., Dilworth, F. J., Bonasoro, J., Jones, G., Petkovich, M. (1997). cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J. Biol. Chem. 272:18538-18541.
107. White, J. C., Shankar, N., Highland, M., Epstein, M. L., DeLuca, H. F., Clagett-Dame, M. (1998). Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid. Proc. Natl. Acad. Sci. U. S. A. 95:13459-13464.
108. White, J. A., Ramshaw, H., Taimi, M., Stangle, W., Zhang, A., Everingham, S., Creighton, S., Tam, S. P., Jones, G., Petkovich, M. (2000). Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc. Natl. Acad. Sci. U. S. A. 97:6403-6408.
109. Willson, T. M., Moore, J. T. (2002). Genomics vs. orphan nuclear receptors - a half-time report. Mol. Endocrinol. 16:1135-1144.
110. Wong, P. Y., Lai, P. S., Falck, J. R. (2000). Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostaglandins Other Lipid Mediat. 62:321-333.
111. Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., Zeldin, D. C. (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J. Biol. Chem. 271:3460-3468.
112. Yu, M., Alonso-Galicia, M., Sun, C. W., Roman, R. J., Ono, N., Hirano, H., Ishimoto, T., Reddy, Y. K., Katipally, K. R., Reddy, K. M., Gopal, V. R., Yu, J., Takhi, M., Falck, J. R. (2003). 20-Hydroxyeicosatetraenoic acid (20-HETE): structural determinants for renal vasoconstriction. Bioorg. Med. Chem. 11:2803-2821.
113. Zhang, Q. Y., Dunbar, D., Kaminsky, L. (2000). Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug Metab. Dispos. 28:292-297.
114. Zimniac, P., Waxman, D. (1993). Liver cytochrome P450 metabolism of endogenous steroid hormones, bile acids, and fatty acids. In: Schenkman, J., Greim, H., eds. Hepatic Cytochrome P450 Monooxygenase Systems. Berlin: Springer-Verlag, pp. 123-144.